Both structures exhibit an overall similar binding architecture, however, ICAM-1-binding residues of A-type and BC-type are distinct and our analysis revealed 9 unique mutations in the DBLβ-interacting residues of ICAM-1 in each structure. The gene discussed is ICAM1; the disease is breast cancer.